<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20201223</date><key>pmc.key</key><document><id>2994226</id><infon key="license">NO-CC CODE</infon><passage><infon key="alt-title">Maternal supplement use and infant leukaemia</infon><infon key="article-id_doi">10.1038/sj.bjc.6605957</infon><infon key="article-id_pii">6605957</infon><infon key="article-id_pmc">2994226</infon><infon key="article-id_pmid">20978510</infon><infon key="fpage">1724</infon><infon key="issue">11</infon><infon key="kwd">epidemiology infants vitamin leukaemia</infon><infon key="lpage">1728</infon><infon key="name_0">surname:Linabery;given-names:A M</infon><infon key="name_1">surname:Puumala;given-names:S E</infon><infon key="name_2">surname:Hilden;given-names:J M</infon><infon key="name_3">surname:Davies;given-names:S M</infon><infon key="name_4">surname:Heerema;given-names:N A</infon><infon key="name_5">surname:Roesler;given-names:M A</infon><infon key="name_6">surname:Ross;given-names:J A</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">103</infon><infon key="year">2010</infon><offset>0</offset><text>Maternal vitamin and iron supplementation and risk of infant leukaemia: a report from the Children's Oncology Group</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>116</offset><text>Background:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>128</offset><text>Prenatal supplementation has been inversely associated with childhood, but not with infant, leukaemia.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>231</offset><text>Methods:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>240</offset><text>Mothers of 443 cases of infant leukaemia diagnosed during 1996â2006 and 324 frequency-matched controls completed interviews. Associations were evaluated by unconditional logistic regression.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>433</offset><text>Results:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>442</offset><text>We observed no associations between prenatal vitamin (odds ratio (OR)=0.79, 95% confidence interval (CI): 0.44â1.42) or iron supplementation (OR=1.07, 95% CI: 0.75â1.52) and infant leukaemia after adjustment for race/ethnicity and income. Similar results were observed for leukaemia subtypes analysed separately.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>759</offset><text>Conclusion</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>770</offset><text>The observed null associations may be attributable to high supplementation rates and/or national fortification programmes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>893</offset><text>Leukaemias diagnosed in infants (&lt;12 months) are distinct from leukaemias in older children/adolescents. Proportions of acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML) cases are more similar among infants (47 vs 37%, respectively) and most cases (ALLs: â¼75%, AMLs: â¼60%) have mixed lineage leukaemia (MLL) gene rearrangements in their leukaemia cells. Monozygotic twins with infant leukaemia have high concordance (â¼100% vs children/adolescents: â¼10%). This observation, coupled with backtracking studies demonstrating that MLL translocations are consistently present at birth in infant cases, provides compelling evidence of in utero initiation.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1570</offset><text>Although there are no established infant leukaemia risk factors, prenatal vitamin supplementation has been inversely associated with childhood ALL (see meta-analysis in), with one study implicating folic acid. Sufficient prenatal folic acid significantly reduces congenital abnormalities. Accordingly, the US Public Health Service recommended â©¾400âÎ¼g of daily folate for women of childbearing age in 1992 and the United States and Canada implemented national fortification programmes during 1996â1998.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2079</offset><text>Prenatal iron supplementation (30âmg per day) is also recommended and has been inconsistently associated with childhood leukaemia. In this study, we investigate the effects of prenatal vitamin and iron supplementation on infant leukaemia risk.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>2325</offset><text>Materials and methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>2347</offset><text>Study methods have been previously published and are described briefly below.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>2425</offset><text>Participant eligibility/identification</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>2464</offset><text>Cases.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>2471</offset><text>Infants (&lt;12 months) with confirmed acute leukaemia diagnoses during two periods (phase 1: January 1996 to October 2002, phase 2: January 2003 to December 2006) were eligible if they were diagnosed/treated at the US or Canadian Children's Oncology Group (COG) institutions, did not have Down syndrome, had physician approval for contact, had biological mothers who spoke English or Spanish (phase 2), consented to participate, and were available by telephone. Deceased cases were eligible.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>2961</offset><text>Controls.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>2971</offset><text>Controls were frequency matched to cases on birth year and location of residence. Controls had biological mothers who spoke English or Spanish, consented to participate, and were available by telephone.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3174</offset><text>In phase 1, controls were identified through random digit dialing (RDD). Owing to secular telephone trends, RDD was undesirable for phase 2. Instead, rosters of potential controls, randomly selected on anticipated birth year distribution, were requested from state birth registries. Subjects were randomly selected from 15 state rosters. If mothers refused, replacement subjects were selected until willing participants were identified.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>3611</offset><text>Data collection</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3627</offset><text>In telephone interviews, mothers were asked whether they consumed vitamin supplements anytime in the year before or during the index pregnancy; in the year before pregnancy; early in but before knowledge of pregnancy; and after knowledge of pregnancy. For each time period, we asked what types of supplements were consumed and whether or not supplements were prescribed by healthcare professionals. Indicator variables were created to assess vitamin use in the periconceptional period (year before pregnancy and early in but before knowledge of pregnancy) and from 1 year before through the index pregnancy. An equivalent set of items concerned iron supplementation exceeding the iron found in multivitamins.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4336</offset><text>Mothers of cases provided diagnostic information, including results of Southern blot, RTâPCR, fluorescent in situ hybridisation, or other cytogenetics testing. Three independent reviewers (SMD, NAH, JMH) evaluated the submitted materials to determine whether there was evidence of MLL gene rearrangement (MLL+, n=228), evidence of no rearrangement (MLLâ, n=146), or insufficient evidence (n=69).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>4736</offset><text>Statistical methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4756</offset><text>Unconditional logistic regression (SAS 9.2, SAS Institute Inc., Cary, NC, USA) was performed to quantify associations between maternal supplement consumption and acute leukaemia among combined cases, and among ALL, AML, MLL+, and MLLâ cases analysed separately. Odds ratios (ORs) and 95% confidence intervals (CIs) were produced. Potential confounders selected a priori are listed in Table 1. Variables were retained in multivariable models if they substantially (â©¾10%) changed ln(OR) estimates, including maternal race/ethnicity (white, black, Hispanic or other) and household income in the child's birth year (â©½$30â000, $30â001â75â000 or &gt;$75â000). Adjustment for matching factors (birth year and region of residence) did not materially alter point estimates; hence, they were not included in the final models.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5585</offset><text>Institutional review boards at the University of Minnesota, participating COG institutions, and states providing birth certificate data (as needed) approved the study.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>5753</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5761</offset><text>Overall, mothers of 443 cases (nALL=264, nAML=172) and 324 controls participated in this study. In phase 1, 240 eligible case (69%) and 255 eligible control (59%) mothers completed interviews. One control was excluded from analysis because the child was found to have Down syndrome during the interview. In phase 2, 345 potential cases were identified through COG institutions, 240 were enroled, and 203 mothers completed interviews (59%). We identified 267 potential birth certificate controls, of which 70 completed and 1 partially completed the interviews (27%). Controls from each phase were similar enough on important demographic factors to merge them in the current analysis.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>6444</offset><text>Cases and controls were similar in infant gender, birth weight, and length of gestation, and in maternal age at index child's birth, previous foetal loss, and smoking during pregnancy (Table 1). More case mothers had &lt;high school diploma (34 vs 28% of control mothers), were non-white (24 vs 15%), had a lower income (36 vs 30% earning â©½$30â000), experienced morning sickness (71 vs 63%), and reported no alcohol consumption during the index pregnancy (86 vs 79%).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>6913</offset><text>Notably, 91% of case and 94% of control mothers reported vitamin use in the year before and/or during the index pregnancy. After adjustment for race/ethnicity and income, there were no associations between vitamin use in the year before and/or during pregnancy (OR=0.79, 95% CI: 0.44â1.42), in the periconceptional period (OR=0.89, 95% CI: 0.64â1.24), after knowledge of pregnancy (OR=0.78, 95% CI: 0.48â1.28), or use over all periods (OR=0.84, 95% CI: 0.62â1.14) and infant leukaemia (Table 2). Restricting exposure to use only after knowledge of pregnancy generated comparable results with those described above (data not shown). Similar results were observed among ALL and AML cases analysed separately (Table 2); ORs for ALL were consistently &lt;1.00, whereas ORs for AML fluctuated around the null. Stratification on MLL translocation status did not provide notable findings (data not shown), with the exception of ALL MLL+ cases, in whom reduced risk was suggested for exposure throughout the periconceptional/prenatal periods (OR=0.66, 95% CI: 0.44â1.00).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7984</offset><text>A number of stratifications were performed to assess the robustness of results. Across the two phases, equal proportions of case mothers reported vitamin use (91% reported any use in both phases) and there was no evidence of heterogeneity of the ORs (data not shown). There was also no detectable heterogeneity on stratification by folic acid fortification period (before, during, and after fortification) or region of residence (six US regions and Canada), although there was limited power to detect differences, given smaller cell counts (data not shown).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8542</offset><text>There was no evidence of an effect of iron supplementation anytime in the year before and/or during pregnancy (OR=1.07, 95% CI: 0.75â1.52), in the periconceptional period (OR=1.23, 95% CI: 0.63â2.38), after knowledge of pregnancy (OR=1.06, 95% CI: 0.74â1.53), or use in all periods (OR=2.54, 95% CI: 0.69â9.39) after accounting for race/ethnicity and income (Table 2). Among those who reported iron supplementation, there was no association between prescription use and infant leukaemia (data not shown). Further analysis by leukaemic subtype (ALL vs AML, MLL+ vs MLLâ) did not yield significant findings (Table 2).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>9168</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9179</offset><text>We found no evidence supporting associations between periconceptional/prenatal vitamin or iron supplementation and infant leukaemia, either overall or for specific aetiological time periods. These results are consistent with other reports regarding infant leukaemia. In contrast, most childhood ALL studies have suggested inverse associations with prenatal vitamin supplementation (with or without iron) and/or with specific periconceptional/prenatal periods. However, no associations have been reported for childhood AML.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9702</offset><text>The reduced odds observed in ALL MLL+ cases may warrant additional study, as folate deficiency is correlated with increased DNA double-strand breaks in blood and bone marrow, and double-strand breaks precede MLL translocations. Further, ALL MLL+ case mothers were expected to recall exposures similar to mothers in other subgroups.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10034</offset><text>Prenatal iron supplementation may indicate low iron levels or anaemia, and maternal anaemia has been associated with childhood leukaemia. These observations, along with inverse associations between prenatal iron supplementation and childhood leukaemia reported by some, suggest that iron deficiency may be related to childhood leukaemia. Conversely, there were no associations between prenatal iron supplementation or gestational anaemia, as documented in medical records, and infant leukaemia in phase 1 of this study, which aligns with our results.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10585</offset><text>This study has strengths and limitations. It comprises the largest study of infant leukaemia conducted to date; previous investigations included 136 and 202 cases. Further, use of the COG registry in case ascertainment results in a nearly population-based study population, as COG institutions see â¼100% of leukaemia cases aged 0â4 years.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10928</offset><text>Differential recall is a concern, as case mothers may exert extra effort to accurately recall exposures. Results of validation studies suggest that, although accuracy of maternal supplementation recall may vary slightly by caseâcontrol status and time period of assessment, resulting effect estimates and aetiological inferences are comparable. In this study, the early age of leukaemia onset limited the recall period.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11350</offset><text>There are other potential sources of misclassification. Most mothers reported taking multi- or prenatal vitamins containing many nutrients, thereby precluding identification of aetiologically relevant component(s). We restricted our analysis and found that 98% consumed vitamins with folic acid; ORs were nearly identical to those in Table 2 (data not shown). We were unable to assess total dietary folate or iron intake because of the limited food frequency questionnaire employed in the interview. However, dietary data from a representative sample of non-pregnant US adults surveyed after fortification suggest that supplement use may be a useful measure of variation in folic acid exposure.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>12045</offset><text>Further, we might only expect to observe an association in the presence of folate deficiency; however, US and Canadian fortification programmes increased folic acid intake among women of childbearing age early in the study period. Of note, neuroblastoma and Wilms tumour incidence rates decreased after Canadian fortification, but no association was observed with infant ALL. The high level of supplementation in our study also limited statistical power.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>12500</offset><text>Differential response rates across cases and controls may indicate selection bias, as study participation and prenatal vitamin use may vary by SES, race, and/or educational attainment. Our prior analysis showed that RDD and birth certificate controls were similar to one another; however, control participants differed from the US population and from non-participants on relevant demographic factors. In this study, we adjusted for maternal race/ethnicity and income, but acknowledge that residual confounding may remain.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13022</offset><text>In contrast to previous childhood leukaemia studies, we did not observe a prenatal vitaminâinfant leukaemia association. This may be attributable to high folic acid supplementation rates, including personal vitamin use and national fortification programs implemented during the study period. Similarly, we did not observe an association with iron supplmentation above that found in multi- or prenatal vitamins.</text></passage><passage><infon key="fpage">2542</infon><infon key="lpage">2546</infon><infon key="name_0">surname:Alexander;given-names:FE</infon><infon key="name_1">surname:Patheal;given-names:SL</infon><infon key="name_10">surname:Hussein;given-names:H</infon><infon key="name_11">surname:Ishii;given-names:E</infon><infon key="name_12">surname:Kamel;given-names:AM</infon><infon key="name_13">surname:Labra;given-names:S</infon><infon key="name_14">surname:Magalhaes;given-names:IQ</infon><infon key="name_15">surname:Mizutani;given-names:S</infon><infon key="name_16">surname:Petridou;given-names:E</infon><infon key="name_17">surname:de Oliveira;given-names:MP</infon><infon key="name_18">surname:Yuen;given-names:P</infon><infon key="name_19">surname:Wiemels;given-names:JL</infon><infon key="name_2">surname:Biondi;given-names:A</infon><infon key="name_20">surname:Greaves;given-names:MF</infon><infon key="name_3">surname:Brandalise;given-names:S</infon><infon key="name_4">surname:Cabrera;given-names:ME</infon><infon key="name_5">surname:Chan;given-names:LC</infon><infon key="name_6">surname:Chen;given-names:Z</infon><infon key="name_7">surname:Cimino;given-names:G</infon><infon key="name_8">surname:Cordoba;given-names:JC</infon><infon key="name_9">surname:Gu;given-names:LJ</infon><infon key="pub-id_pmid">11289128</infon><infon key="section_type">REF</infon><infon key="source">Cancer Res</infon><infon key="type">ref</infon><infon key="volume">61</infon><infon key="year">2001</infon><offset>13435</offset><text>Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion</text></passage><passage><infon key="fpage">3290</infon><infon key="lpage">3295</infon><infon key="name_0">surname:Blount;given-names:BC</infon><infon key="name_1">surname:Mack;given-names:MM</infon><infon key="name_2">surname:Wehr;given-names:CM</infon><infon key="name_3">surname:MacGregor;given-names:JT</infon><infon key="name_4">surname:Hiatt;given-names:RA</infon><infon key="name_5">surname:Wang;given-names:G</infon><infon key="name_6">surname:Wickramasinghe;given-names:SN</infon><infon key="name_7">surname:Everson;given-names:RB</infon><infon key="name_8">surname:Ames;given-names:BN</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">1997</infon><offset>13517</offset><text>Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage</text></passage><passage><infon key="fpage">841</infon><infon key="lpage">842</infon><infon key="name_0">surname:Burton;given-names:A</infon><infon key="name_1">surname:Wilson;given-names:S</infon><infon key="name_2">surname:Gillies;given-names:AJ</infon><infon key="pub-id_pmid">11604442</infon><infon key="section_type">REF</infon><infon key="source">J Epidemiol Community Health</infon><infon key="type">ref</infon><infon key="volume">55</infon><infon key="year">2001</infon><offset>13650</offset><text>Folic acid: is self reported use of supplements accurate</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">7</infon><infon key="section_type">REF</infon><infon key="source">MMWR Recomm Rep</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">1992</infon><offset>13707</offset><text>Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">29</infon><infon key="section_type">REF</infon><infon key="source">MMWR Recomm Rep</infon><infon key="type">ref</infon><infon key="volume">47</infon><infon key="year">1998</infon><offset>13825</offset><text>Recommendations to prevent and control iron deficiency in the United States</text></passage><passage><infon key="fpage">962</infon><infon key="lpage">965</infon><infon key="pub-id_pmid">11093616</infon><infon key="section_type">REF</infon><infon key="source">MMWR Morb Mortal Wkly Rep</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="year">2000</infon><offset>13901</offset><text>Folate status in women of childbearing age â United States, 1999</text></passage><passage><infon key="fpage">136</infon><infon key="name_0">surname:Dockerty;given-names:JD</infon><infon key="name_1">surname:Herbison;given-names:P</infon><infon key="name_2">surname:Skegg;given-names:DC</infon><infon key="name_3">surname:Elwood;given-names:M</infon><infon key="pub-id_pmid">17605825</infon><infon key="section_type">REF</infon><infon key="source">BMC Public Health</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2007</infon><offset>13968</offset><text>Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case-control study</text></passage><passage><infon key="fpage">405</infon><infon key="lpage">411</infon><infon key="name_0">surname:Drews;given-names:CD</infon><infon key="name_1">surname:Kraus;given-names:JF</infon><infon key="name_2">surname:Greenland;given-names:S</infon><infon key="pub-id_pmid">2376455</infon><infon key="section_type">REF</infon><infon key="source">Int J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">1990</infon><offset>14091</offset><text>Recall bias in a case-control study of sudden infant death syndrome</text></passage><passage><infon key="fpage">8781</infon><infon key="lpage">8797</infon><infon key="section_type">REF</infon><infon key="source">Fed Regist</infon><infon key="type">ref</infon><infon key="volume">61</infon><infon key="year">1996</infon><offset>14159</offset><text>Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid</text></passage><passage><infon key="fpage">288</infon><infon key="lpage">294</infon><infon key="name_0">surname:French;given-names:AE</infon><infon key="name_1">surname:Grant;given-names:R</infon><infon key="name_2">surname:Weitzman;given-names:S</infon><infon key="name_3">surname:Ray;given-names:JG</infon><infon key="name_4">surname:Vermeulen;given-names:MJ</infon><infon key="name_5">surname:Sung;given-names:L</infon><infon key="name_6">surname:Greenberg;given-names:M</infon><infon key="name_7">surname:Koren;given-names:G</infon><infon key="pub-id_pmid">12966372</infon><infon key="section_type">REF</infon><infon key="source">Clin Pharmacol Ther</infon><infon key="type">ref</infon><infon key="volume">74</infon><infon key="year">2003</infon><offset>14272</offset><text>Folic acid food fortification is associated with a decline in neuroblastoma</text></passage><passage><infon key="fpage">13950</infon><infon key="lpage">13954</infon><infon key="name_0">surname:Gale;given-names:KB</infon><infon key="name_1">surname:Ford;given-names:AM</infon><infon key="name_2">surname:Repp;given-names:R</infon><infon key="name_3">surname:Borkhardt;given-names:A</infon><infon key="name_4">surname:Keller;given-names:C</infon><infon key="name_5">surname:Eden;given-names:OB</infon><infon key="name_6">surname:Greaves;given-names:MF</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">1997</infon><offset>14348</offset><text>Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots</text></passage><passage><infon key="fpage">372</infon><infon key="lpage">377</infon><infon key="name_0">surname:Greaves;given-names:MF</infon><infon key="pub-id_pmid">8637251</infon><infon key="section_type">REF</infon><infon key="source">Leukemia</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">1996</infon><offset>14455</offset><text>Infant leukaemia biology, aetiology and treatment</text></passage><passage><infon key="fpage">2321</infon><infon key="lpage">2333</infon><infon key="name_0">surname:Greaves;given-names:MF</infon><infon key="name_1">surname:Maia;given-names:AT</infon><infon key="name_2">surname:Wiemels;given-names:JL</infon><infon key="name_3">surname:Ford;given-names:AM</infon><infon key="pub-id_pmid">12791663</infon><infon key="section_type">REF</infon><infon key="source">Blood</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="year">2003</infon><offset>14505</offset><text>Leukemia in twins: lessons in natural history</text></passage><passage><infon key="name_0">surname:Grupp;given-names:SG</infon><infon key="name_1">surname:Greenberg;given-names:ML</infon><infon key="name_2">surname:Ray;given-names:JG</infon><infon key="name_3">surname:Busto;given-names:U</infon><infon key="name_4">surname:Lanctot;given-names:KL</infon><infon key="name_5">surname:Nulman;given-names:I</infon><infon key="name_6">surname:Koren;given-names:G</infon><infon key="pub-id_doi">10.1177/0091270010365553</infon><infon key="section_type">REF</infon><infon key="source">J Clin Pharmacol</infon><infon key="type">ref</infon><infon key="year">2010</infon><offset>14551</offset><text>Pediatric cancer rates after universal folic acid flour fortification in Ontario</text></passage><passage><infon key="fpage">2981</infon><infon key="lpage">2986</infon><infon key="name_0">surname:Honein;given-names:MA</infon><infon key="name_1">surname:Paulozzi;given-names:LJ</infon><infon key="name_2">surname:Mathews;given-names:TJ</infon><infon key="name_3">surname:Erickson;given-names:JD</infon><infon key="name_4">surname:Wong;given-names:LY</infon><infon key="pub-id_pmid">11410096</infon><infon key="section_type">REF</infon><infon key="source">JAMA</infon><infon key="type">ref</infon><infon key="volume">285</infon><infon key="year">2001</infon><offset>14632</offset><text>Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects</text></passage><passage><infon key="fpage">95</infon><infon key="lpage">99</infon><infon key="name_0">surname:Johnson;given-names:KJ</infon><infon key="name_1">surname:Roesler;given-names:MA</infon><infon key="name_2">surname:Linabery;given-names:AM</infon><infon key="name_3">surname:Hilden;given-names:JM</infon><infon key="name_4">surname:Davies;given-names:SM</infon><infon key="name_5">surname:Ross;given-names:JA</infon><infon key="pub-id_pmid">20486175</infon><infon key="section_type">REF</infon><infon key="source">Pediatr Blood Cancer</infon><infon key="type">ref</infon><infon key="volume">55</infon><infon key="year">2010</infon><offset>14730</offset><text>Infant leukemia and congenital abnormalities: a Children's Oncology Group study</text></passage><passage><infon key="fpage">27</infon><infon key="lpage">35</infon><infon key="name_0">surname:Kwan;given-names:ML</infon><infon key="name_1">surname:Metayer;given-names:C</infon><infon key="name_2">surname:Crouse;given-names:V</infon><infon key="name_3">surname:Buffler;given-names:PA</infon><infon key="pub-id_pmid">17035343</infon><infon key="section_type">REF</infon><infon key="source">Am J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">165</infon><infon key="year">2007</infon><offset>14810</offset><text>Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring</text></passage><passage><infon key="fpage">181</infon><infon key="lpage">186</infon><infon key="name_0">surname:Langley-Evans;given-names:SC</infon><infon key="name_1">surname:Langley-Evans;given-names:AJ</infon><infon key="section_type">REF</infon><infon key="source">J R Soc Health</infon><infon key="type">ref</infon><infon key="volume">122</infon><infon key="year">2002</infon><offset>14938</offset><text>Use of folic acid supplements in the first trimester of pregnancy</text></passage><passage><infon key="fpage">350</infon><infon key="lpage">355</infon><infon key="name_0">surname:Law;given-names:GR</infon><infon key="name_1">surname:Smith;given-names:AG</infon><infon key="name_2">surname:Roman;given-names:E</infon><infon key="pub-id_pmid">11875698</infon><infon key="section_type">REF</infon><infon key="source">Br J Cancer</infon><infon key="type">ref</infon><infon key="volume">86</infon><infon key="year">2002</infon><offset>15004</offset><text>The importance of full participation: lessons from a national case-control study</text></passage><passage><infon key="fpage">416</infon><infon key="lpage">432</infon><infon key="name_0">surname:Linabery;given-names:AM</infon><infon key="name_1">surname:Ross;given-names:JA</infon><infon key="pub-id_pmid">18074355</infon><infon key="section_type">REF</infon><infon key="source">Cancer</infon><infon key="type">ref</infon><infon key="volume">112</infon><infon key="year">2008</infon><offset>15085</offset><text>Trends in childhood cancer incidence in the U.S. (1992â2004)</text></passage><passage><infon key="fpage">65</infon><infon key="lpage">75</infon><infon key="name_0">surname:Mackenzie;given-names:SG</infon><infon key="name_1">surname:Lippman;given-names:A</infon><infon key="pub-id_pmid">2910073</infon><infon key="section_type">REF</infon><infon key="source">Am J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">129</infon><infon key="year">1989</infon><offset>15148</offset><text>An investigation of report bias in a case-control study of pregnancy outcome</text></passage><passage><infon key="fpage">1844</infon><infon key="lpage">1851</infon><infon key="name_0">surname:McKinney;given-names:PA</infon><infon key="name_1">surname:Juszczak;given-names:E</infon><infon key="name_2">surname:Findlay;given-names:E</infon><infon key="name_3">surname:Smith;given-names:K</infon><infon key="name_4">surname:Thomson;given-names:CS</infon><infon key="pub-id_pmid">10468308</infon><infon key="section_type">REF</infon><infon key="source">Br J Cancer</infon><infon key="type">ref</infon><infon key="volume">80</infon><infon key="year">1999</infon><offset>15225</offset><text>Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study</text></passage><passage><infon key="fpage">2690</infon><infon key="lpage">2699</infon><infon key="name_0">surname:Milne;given-names:E</infon><infon key="name_1">surname:Royle;given-names:JA</infon><infon key="name_10">surname:Haber;given-names:M</infon><infon key="name_11">surname:Thompson;given-names:JR</infon><infon key="name_12">surname:Fritschi;given-names:L</infon><infon key="name_13">surname:Marshall;given-names:GM</infon><infon key="name_14">surname:Armstrong;given-names:BK</infon><infon key="name_2">surname:Miller;given-names:M</infon><infon key="name_3">surname:Bower;given-names:C</infon><infon key="name_4">surname:de Klerk;given-names:NH</infon><infon key="name_5">surname:Bailey;given-names:HD</infon><infon key="name_6">surname:van Bockxmeer;given-names:F</infon><infon key="name_7">surname:Attia;given-names:J</infon><infon key="name_8">surname:Scott;given-names:RJ</infon><infon key="name_9">surname:Norris;given-names:MD</infon><infon key="pub-id_pmid">19839053</infon><infon key="section_type">REF</infon><infon key="source">Int J Cancer</infon><infon key="type">ref</infon><infon key="volume">126</infon><infon key="year">2010</infon><offset>15335</offset><text>Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring</text></passage><passage><infon key="fpage">131</infon><infon key="lpage">137</infon><infon key="pub-id_pmid">1677062</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">338</infon><infon key="year">1991</infon><offset>15460</offset><text>Prevention of neural tube defects: results of the Medical Research Council Vitamin Study</text></passage><passage><infon key="fpage">1274</infon><infon key="lpage">1276</infon><infon key="name_0">surname:Peters;given-names:AM</infon><infon key="name_1">surname:Blair;given-names:CK</infon><infon key="name_2">surname:Verneris;given-names:MR</infon><infon key="name_3">surname:Neglia;given-names:JP</infon><infon key="name_4">surname:Robison;given-names:LL</infon><infon key="name_5">surname:Spector;given-names:LG</infon><infon key="name_6">surname:Reaman;given-names:GH</infon><infon key="name_7">surname:Felix;given-names:CA</infon><infon key="name_8">surname:Ross;given-names:JA</infon><infon key="pub-id_pmid">17003777</infon><infon key="section_type">REF</infon><infon key="source">Br J Cancer</infon><infon key="type">ref</infon><infon key="volume">95</infon><infon key="year">2006</infon><offset>15549</offset><text>Maternal hemoglobin concentration during pregnancy and risk of infant leukaemia: a children's oncology group study</text></passage><passage><infon key="fpage">1241</infon><infon key="lpage">1247</infon><infon key="name_0">surname:Petridou;given-names:E</infon><infon key="name_1">surname:Trichopoulos;given-names:D</infon><infon key="name_10">surname:Tzortzatou;given-names:F</infon><infon key="name_2">surname:Kalapothaki;given-names:V</infon><infon key="name_3">surname:Pourtsidis;given-names:A</infon><infon key="name_4">surname:Kogevinas;given-names:M</infon><infon key="name_5">surname:Kalmanti;given-names:M</infon><infon key="name_6">surname:Koliouskas;given-names:D</infon><infon key="name_7">surname:Kosmidis;given-names:H</infon><infon key="name_8">surname:Panagiotou;given-names:JP</infon><infon key="name_9">surname:Piperopoulou;given-names:F</infon><infon key="pub-id_pmid">9365177</infon><infon key="section_type">REF</infon><infon key="source">Br J Cancer</infon><infon key="type">ref</infon><infon key="volume">76</infon><infon key="year">1997</infon><offset>15664</offset><text>The risk profile of childhood leukaemia in Greece: a nationwide case-control study</text></passage><passage><infon key="fpage">2336</infon><infon key="lpage">2341</infon><infon key="name_0">surname:Pombo-de-Oliveira;given-names:MS</infon><infon key="name_1">surname:Koifman;given-names:S</infon><infon key="pub-id_pmid">17164354</infon><infon key="section_type">REF</infon><infon key="source">Cancer Epidemiol Biomarkers Prev</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2006</infon><offset>15747</offset><text>Infant acute leukemia and maternal exposures during pregnancy</text></passage><passage><infon key="fpage">762</infon><infon key="lpage">769</infon><infon key="name_0">surname:Pui;given-names:CH</infon><infon key="name_1">surname:Kane;given-names:JR</infon><infon key="name_2">surname:Crist;given-names:WM</infon><infon key="pub-id_pmid">7769837</infon><infon key="section_type">REF</infon><infon key="source">Leukemia</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1995</infon><offset>15809</offset><text>Biology and treatment of infant leukemias</text></passage><passage><infon key="fpage">379</infon><infon key="lpage">387</infon><infon key="name_0">surname:Puumala;given-names:SE</infon><infon key="name_1">surname:Spector;given-names:LG</infon><infon key="name_2">surname:Robison;given-names:LL</infon><infon key="name_3">surname:Bunin;given-names:GR</infon><infon key="name_4">surname:Olshan;given-names:AF</infon><infon key="name_5">surname:Linabery;given-names:AM</infon><infon key="name_6">surname:Roesler;given-names:MA</infon><infon key="name_7">surname:Blair;given-names:CK</infon><infon key="name_8">surname:Ross;given-names:JA</infon><infon key="pub-id_pmid">19498073</infon><infon key="section_type">REF</infon><infon key="source">Am J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">170</infon><infon key="year">2009</infon><offset>15851</offset><text>Comparability and representativeness of control groups in a case-control study of infant leukemia: a report from the Children's Oncology Group</text></passage><passage><infon key="fpage">1561</infon><infon key="lpage">1568</infon><infon key="name_0">surname:Puumala;given-names:SE</infon><infon key="name_1">surname:Spector;given-names:LG</infon><infon key="name_2">surname:Wall;given-names:MM</infon><infon key="name_3">surname:Robison;given-names:LL</infon><infon key="name_4">surname:Heerema;given-names:NA</infon><infon key="name_5">surname:Roesler;given-names:MA</infon><infon key="name_6">surname:Ross;given-names:JA</infon><infon key="pub-id_pmid">20382971</infon><infon key="section_type">REF</infon><infon key="source">Hum Reprod</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2010</infon><offset>15994</offset><text>Infant leukemia and parental infertility or its treatment: a Children's Oncology Group report</text></passage><passage><infon key="fpage">2047</infon><infon key="lpage">2048</infon><infon key="name_0">surname:Ray;given-names:JG</infon><infon key="name_1">surname:Meier;given-names:C</infon><infon key="name_2">surname:Vermeulen;given-names:MJ</infon><infon key="name_3">surname:Boss;given-names:S</infon><infon key="name_4">surname:Wyatt;given-names:PR</infon><infon key="name_5">surname:Cole;given-names:DE</infon><infon key="pub-id_pmid">12504403</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">360</infon><infon key="year">2002a</infon><offset>16088</offset><text>Association of neural tube defects and folic acid food fortification in Canada</text></passage><passage><infon key="fpage">238</infon><infon key="lpage">240</infon><infon key="name_0">surname:Ray;given-names:JG</infon><infon key="name_1">surname:Vermeulen;given-names:MJ</infon><infon key="name_2">surname:Boss;given-names:SC</infon><infon key="name_3">surname:Cole;given-names:DE</infon><infon key="pub-id_pmid">11880771</infon><infon key="section_type">REF</infon><infon key="source">Epidemiology</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2002b</infon><offset>16167</offset><text>Increased red cell folate concentrations in women of reproductive age after Canadian folic acid food fortification</text></passage><passage><infon key="fpage">3035</infon><infon key="lpage">3044</infon><infon key="name_0">surname:Reichel;given-names:M</infon><infon key="name_1">surname:Gillert;given-names:E</infon><infon key="name_2">surname:Nilson;given-names:I</infon><infon key="name_3">surname:Siegler;given-names:G</infon><infon key="name_4">surname:Greil;given-names:J</infon><infon key="name_5">surname:Fey;given-names:GH</infon><infon key="name_6">surname:Marschalek;given-names:R</infon><infon key="pub-id_pmid">9881706</infon><infon key="section_type">REF</infon><infon key="source">Oncogene</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1998</infon><offset>16282</offset><text>Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation</text></passage><passage><infon key="fpage">571</infon><infon key="lpage">582</infon><infon key="name_0">surname:Robien;given-names:K</infon><infon key="name_1">surname:Ulrich;given-names:CM</infon><infon key="pub-id_pmid">12672676</infon><infon key="section_type">REF</infon><infon key="source">Am J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">157</infon><infon key="year">2003</infon><offset>16430</offset><text>5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview</text></passage><passage><infon key="fpage">1904</infon><infon key="lpage">1911</infon><infon key="name_0">surname:Robison;given-names:LL</infon><infon key="name_1">surname:Buckley;given-names:JD</infon><infon key="name_2">surname:Daigle;given-names:AE</infon><infon key="name_3">surname:Wells;given-names:R</infon><infon key="name_4">surname:Benjamin;given-names:D</infon><infon key="name_5">surname:Arthur;given-names:DC</infon><infon key="name_6">surname:Hammond;given-names:GD</infon><infon key="pub-id_pmid">2649219</infon><infon key="section_type">REF</infon><infon key="source">Cancer</infon><infon key="type">ref</infon><infon key="volume">63</infon><infon key="year">1989</infon><offset>16522</offset><text>Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group)</text></passage><passage><infon key="fpage">164</infon><infon key="lpage">166</infon><infon key="name_0">surname:Robison;given-names:LL</infon><infon key="name_1">surname:Daigle;given-names:A</infon><infon key="pub-id_pmid">6741917</infon><infon key="section_type">REF</infon><infon key="source">Am J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">120</infon><infon key="year">1984</infon><offset>16707</offset><text>Control selection using random digit dialing for cases of childhood cancer</text></passage><passage><infon key="fpage">406</infon><infon key="lpage">415</infon><infon key="name_0">surname:Roman;given-names:E</infon><infon key="name_1">surname:Ansell;given-names:P</infon><infon key="name_2">surname:Bull;given-names:D</infon><infon key="pub-id_pmid">9252212</infon><infon key="section_type">REF</infon><infon key="source">Br J Cancer</infon><infon key="type">ref</infon><infon key="volume">76</infon><infon key="year">1997</infon><offset>16782</offset><text>Leukaemia and non-Hodgkin's lymphoma in children and young adults: are prenatal and neonatal factors important determinants of disease</text></passage><passage><infon key="fpage">749</infon><infon key="lpage">759</infon><infon key="name_0">surname:Roman;given-names:E</infon><infon key="name_1">surname:Simpson;given-names:J</infon><infon key="name_2">surname:Ansell;given-names:P</infon><infon key="name_3">surname:Lightfoot;given-names:T</infon><infon key="name_4">surname:Mitchell;given-names:C</infon><infon key="name_5">surname:Eden;given-names:TO</infon><infon key="pub-id_pmid">15763652</infon><infon key="section_type">REF</infon><infon key="source">Eur J Cancer</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">2005</infon><offset>16917</offset><text>Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS</text></passage><passage><infon key="fpage">405</infon><infon key="lpage">410</infon><infon key="name_0">surname:Ross;given-names:JA</infon><infon key="name_1">surname:Blair;given-names:CK</infon><infon key="name_2">surname:Olshan;given-names:AF</infon><infon key="name_3">surname:Robison;given-names:LL</infon><infon key="name_4">surname:Smith;given-names:FO</infon><infon key="name_5">surname:Heerema;given-names:NA</infon><infon key="name_6">surname:Roesler;given-names:M</infon><infon key="pub-id_pmid">15952191</infon><infon key="section_type">REF</infon><infon key="source">Cancer</infon><infon key="type">ref</infon><infon key="volume">104</infon><infon key="year">2005</infon><offset>17008</offset><text>Periconceptional vitamin use and leukemia risk in children with Down syndrome: a Children's Oncology Group study</text></passage><passage><infon key="fpage">201</infon><infon key="lpage">207</infon><infon key="name_0">surname:Ross;given-names:JA</infon><infon key="name_1">surname:Severson;given-names:RK</infon><infon key="name_2">surname:Pollock;given-names:BH</infon><infon key="name_3">surname:Robison;given-names:LL</infon><infon key="pub-id_pmid">8630931</infon><infon key="section_type">REF</infon><infon key="source">Cancer</infon><infon key="type">ref</infon><infon key="volume">77</infon><infon key="year">1996</infon><offset>17121</offset><text>Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups</text></passage><passage><infon key="fpage">922</infon><infon key="lpage">924</infon><infon key="name_0">surname:Ross;given-names:JA</infon><infon key="name_1">surname:Spector;given-names:LG</infon><infon key="name_2">surname:Olshan;given-names:AF</infon><infon key="name_3">surname:Bunin;given-names:GR</infon><infon key="pub-id_pmid">15128602</infon><infon key="section_type">REF</infon><infon key="source">Am J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">159</infon><infon key="year">2004</infon><offset>17247</offset><text>Invited commentary: birth certificates â a best control scenario</text></passage><passage><infon key="fpage">141</infon><infon key="lpage">148</infon><infon key="name_0">surname:Sarasua;given-names:S</infon><infon key="name_1">surname:Savitz;given-names:DA</infon><infon key="pub-id_pmid">8167261</infon><infon key="section_type">REF</infon><infon key="source">Cancer Causes Control</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">1994</infon><offset>17314</offset><text>Cured and broiled meat consumption in relation to childhood cancer: Denver, Colorado (United States)</text></passage><passage><infon key="fpage">433</infon><infon key="lpage">441</infon><infon key="name_0">surname:Schuz;given-names:J</infon><infon key="name_1">surname:Weihkopf;given-names:T</infon><infon key="name_2">surname:Kaatsch;given-names:P</infon><infon key="pub-id_pmid">17345098</infon><infon key="section_type">REF</infon><infon key="source">Eur J Pediatr</infon><infon key="type">ref</infon><infon key="volume">166</infon><infon key="year">2007</infon><offset>17415</offset><text>Medication use during pregnancy and the risk of childhood cancer in the offspring</text></passage><passage><infon key="fpage">651</infon><infon key="lpage">655</infon><infon key="name_0">surname:Spector;given-names:LG</infon><infon key="name_1">surname:Xie;given-names:Y</infon><infon key="name_10">surname:Blair;given-names:CK</infon><infon key="name_11">surname:Reaman;given-names:GH</infon><infon key="name_12">surname:Ross;given-names:JA</infon><infon key="name_2">surname:Robison;given-names:LL</infon><infon key="name_3">surname:Heerema;given-names:NA</infon><infon key="name_4">surname:Hilden;given-names:JM</infon><infon key="name_5">surname:Lange;given-names:B</infon><infon key="name_6">surname:Felix;given-names:CA</infon><infon key="name_7">surname:Davies;given-names:SM</infon><infon key="name_8">surname:Slavin;given-names:J</infon><infon key="name_9">surname:Potter;given-names:JD</infon><infon key="pub-id_pmid">15767345</infon><infon key="section_type">REF</infon><infon key="source">Cancer Epidemiol Biomarkers Prev</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2005</infon><offset>17497</offset><text>Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group</text></passage><passage><infon key="fpage">1935</infon><infon key="lpage">1940</infon><infon key="name_0">surname:Thompson;given-names:JR</infon><infon key="name_1">surname:Gerald;given-names:PF</infon><infon key="name_2">surname:Willoughby;given-names:ML</infon><infon key="name_3">surname:Armstrong;given-names:BK</infon><infon key="pub-id_pmid">11747917</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">358</infon><infon key="year">2001</infon><offset>17623</offset><text>Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study</text></passage><passage><infon key="fpage">1786</infon><infon key="lpage">1794</infon><infon key="name_0">surname:Wen;given-names:W</infon><infon key="name_1">surname:Shu;given-names:XO</infon><infon key="name_2">surname:Potter;given-names:JD</infon><infon key="name_3">surname:Severson;given-names:RK</infon><infon key="name_4">surname:Buckley;given-names:JD</infon><infon key="name_5">surname:Reaman;given-names:GH</infon><infon key="name_6">surname:Robison;given-names:LL</infon><infon key="pub-id_pmid">12365028</infon><infon key="section_type">REF</infon><infon key="source">Cancer</infon><infon key="type">ref</infon><infon key="volume">95</infon><infon key="year">2002</infon><offset>17756</offset><text>Parental medication use and risk of childhood acute lymphoblastic leukemia</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">14</infon><infon key="name_0">surname:Williams;given-names:LM</infon><infon key="name_1">surname:Morrow;given-names:B</infon><infon key="name_2">surname:Lansky;given-names:A</infon><infon key="name_3">surname:Beck;given-names:LF</infon><infon key="name_4">surname:Barfield;given-names:W</infon><infon key="name_5">surname:Helms;given-names:K</infon><infon key="name_6">surname:Lipscomb;given-names:L</infon><infon key="name_7">surname:Whitehead;given-names:N</infon><infon key="section_type">REF</infon><infon key="source">MMWR Surveill Summ</infon><infon key="type">ref</infon><infon key="volume">52</infon><infon key="year">2003</infon><offset>17831</offset><text>Surveillance for selected maternal behaviors and experiences before, during, and after pregnancy. Pregnancy Risk Assessment Monitoring System (PRAMS), 2000</text></passage><passage><infon key="fpage">2486</infon><infon key="lpage">2487</infon><infon key="name_0">surname:Yeung;given-names:L</infon><infon key="name_1">surname:Yang;given-names:Q</infon><infon key="name_2">surname:Berry;given-names:RJ</infon><infon key="pub-id_pmid">19050191</infon><infon key="section_type">REF</infon><infon key="source">JAMA</infon><infon key="type">ref</infon><infon key="volume">300</infon><infon key="year">2008</infon><offset>17987</offset><text>Contributions of total daily intake of folic acid to serum folate concentrations</text></passage><passage><infon key="file">tbl1.xml</infon><infon key="id">tbl1</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>18068</offset><text>Selected characteristics of 443 infant leukaemia cases and 324 controls</text></passage><passage><infon key="file">tbl1.xml</infon><infon key="id">tbl1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; border=&quot;1&quot;&gt;&lt;colgroup&gt;&lt;col align=&quot;left&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;(&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;(&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;.&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;â&quot;/&gt;&lt;/colgroup&gt;&lt;thead valign=&quot;bottom&quot;&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;Â &lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;Controls&lt;/bold&gt;&lt;/th&gt;&lt;th colspan=&quot;3&quot; align=&quot;center&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;Combined cases&lt;/bold&gt;&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;Â &lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;&lt;italic&gt;N&lt;/italic&gt; (%)&lt;/bold&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;&lt;italic&gt;N&lt;/italic&gt; (%)&lt;/bold&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;OR&lt;/bold&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;95% CI&lt;/bold&gt;&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody valign=&quot;top&quot;&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;&lt;italic&gt;Infant characteristics&lt;/italic&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âGender&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââMale&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;156 (48.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;218 (49.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââFemale&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;168 (51.9)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;225 (50.8)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.96&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.72â1.28&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âBirth weight&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ&amp;lt;2500âg&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;17 (5.3)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;23 (5.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.99&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.52â1.90&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ2500â4000âg&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;258 (79.6)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;351 (79.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ&amp;gt;4000âg&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;49 (15.1)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;69 (15.6)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.04&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.69â1.54&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âLength of gestation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ&amp;lt;38 weeks&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;35 (10.8)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;55 (12.4)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.17&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.75â1.84&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ38â42 weeks&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;288 (88.9)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;387 (87.4)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ&amp;gt;42 weeks&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;1 (0.3)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;1 (0.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.74&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.05â11.95&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;&lt;italic&gt;Maternal characteristics&lt;/italic&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âAge at index child's birth&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ&amp;lt;35 years&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;265 (82.0)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;372 (84.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âââ©¾35 years&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;58 (18.0)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;70 (15.8)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.86&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.59â1.26&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âPrevious foetal loss&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNone&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;241 (74.4)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;337 (76.1)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ1&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;64 (19.8)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;76 (17.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.85&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.59â1.23&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âââ©¾2&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;19 (5.9)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;30 (6.8)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.13&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.62â2.05&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âEducational attainment&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ&amp;lt;High school graduate&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;91 (28.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;149 (33.7)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.47&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;1.02â2.11&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââSome post-high school&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;112 (34.7)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;125 (28.3)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââCollege graduate&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;120 (37.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;168 (38.0)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.25&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.89â1.77&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âRace/Ethnicity&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââWhite&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;273 (84.5)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;334 (75.6)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââAfrican-American&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;18 (5.6)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;18 (4.1)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.82&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.42â1.60&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââHispanic&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;15 (4.6)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;55 (12.4)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;3.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;1.66â5.42&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââOther&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;17 (5.3)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;35 (7.9)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.68&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.92â3.07&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âHousehold income&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âââ©½$30â000&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;95 (29.6)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;157 (35.8)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.27&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.91â1.77&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ$30â001â75â000&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;145 (45.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;189 (43.1)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââ&amp;gt;$75â000&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;81 (25.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;93 (21.2)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.88&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.61â1.27&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âMorning sickness&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;120 (37.0)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;128 (28.9)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;204 (63.0)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;315 (71.1)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.45&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;1.07â1.96&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âSmoking during pregnancy&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;258 (79.9)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;368 (83.3)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;65 (20.1)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;74 (16.7)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.80&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.55â1.15&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;5&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âDrinking during pregnancy&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;254 (78.6)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;377 (85.7)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;69 (21.4)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;(&quot; charoff=&quot;50&quot;&gt;63 (14.3)&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.62&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.42â0.90&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>18140</offset><text>Â 	Controls	Combined cases	 	Â 	N (%)	N (%)	OR	95% CI	 	Infant characteristics	 	âGender	 	ââMale	156 (48.2)	218 (49.2)	1.00	Â 	 	ââFemale	168 (51.9)	225 (50.8)	0.96	0.72â1.28	 	âBirth weight	 	ââ&lt;2500âg	17 (5.3)	23 (5.2)	0.99	0.52â1.90	 	ââ2500â4000âg	258 (79.6)	351 (79.2)	1.00	Â 	 	ââ&gt;4000âg	49 (15.1)	69 (15.6)	1.04	0.69â1.54	 	âLength of gestation	 	ââ&lt;38 weeks	35 (10.8)	55 (12.4)	1.17	0.75â1.84	 	ââ38â42 weeks	288 (88.9)	387 (87.4)	1.00	Â 	 	ââ&gt;42 weeks	1 (0.3)	1 (0.2)	0.74	0.05â11.95	 	Â 	Â 	Â 	Â 	Â 	 	Maternal characteristics	 	âAge at index child's birth	 	ââ&lt;35 years	265 (82.0)	372 (84.2)	1.00	Â 	 	âââ©¾35 years	58 (18.0)	70 (15.8)	0.86	0.59â1.26	 	âPrevious foetal loss	 	ââNone	241 (74.4)	337 (76.1)	1.00	Â 	 	ââ1	64 (19.8)	76 (17.2)	0.85	0.59â1.23	 	âââ©¾2	19 (5.9)	30 (6.8)	1.13	0.62â2.05	 	âEducational attainment	 	ââ&lt;High school graduate	91 (28.2)	149 (33.7)	1.47	1.02â2.11	 	ââSome post-high school	112 (34.7)	125 (28.3)	1.00	Â 	 	ââCollege graduate	120 (37.2)	168 (38.0)	1.25	0.89â1.77	 	âRace/Ethnicity	 	ââWhite	273 (84.5)	334 (75.6)	1.00	Â 	 	ââAfrican-American	18 (5.6)	18 (4.1)	0.82	0.42â1.60	 	ââHispanic	15 (4.6)	55 (12.4)	3.00	1.66â5.42	 	ââOther	17 (5.3)	35 (7.9)	1.68	0.92â3.07	 	âHousehold income	 	âââ©½$30â000	95 (29.6)	157 (35.8)	1.27	0.91â1.77	 	ââ$30â001â75â000	145 (45.2)	189 (43.1)	1.00	Â 	 	ââ&gt;$75â000	81 (25.2)	93 (21.2)	0.88	0.61â1.27	 	âMorning sickness	 	ââNo	120 (37.0)	128 (28.9)	1.00	Â 	 	ââYes	204 (63.0)	315 (71.1)	1.45	1.07â1.96	 	âSmoking during pregnancy	 	ââNo	258 (79.9)	368 (83.3)	1.00	Â 	 	ââYes	65 (20.1)	74 (16.7)	0.80	0.55â1.15	 	âDrinking during pregnancy	 	ââNo	254 (78.6)	377 (85.7)	1.00	Â 	 	ââYes	69 (21.4)	63 (14.3)	0.62	0.42â0.90	 	</text></passage><passage><infon key="file">tbl1.xml</infon><infon key="id">tbl1</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>20037</offset><text>Abbreviations: 95% CI=95% confidence interval; OR=odds ratio.</text></passage><passage><infon key="file">tbl2.xml</infon><infon key="id">tbl2</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>20099</offset><text>Association of vitamin use and infant leukaemia</text></passage><passage><infon key="file">tbl2.xml</infon><infon key="id">tbl2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; border=&quot;1&quot;&gt;&lt;colgroup&gt;&lt;col align=&quot;left&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;.&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;.&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;.&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;â&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;.&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;.&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;â&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;.&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;.&quot;/&gt;&lt;col align=&quot;char&quot; char=&quot;â&quot;/&gt;&lt;/colgroup&gt;&lt;thead valign=&quot;bottom&quot;&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;Â &lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;Controls&lt;/bold&gt;&lt;/th&gt;&lt;th colspan=&quot;3&quot; align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;Combined cases&lt;/bold&gt;&lt;/th&gt;&lt;th colspan=&quot;3&quot; align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;ALL&lt;/bold&gt;&lt;/th&gt;&lt;th colspan=&quot;3&quot; align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;AML&lt;/bold&gt;&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;Â &lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;&lt;italic&gt;N&lt;/italic&gt;&lt;/bold&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;&lt;italic&gt;N&lt;/italic&gt;&lt;/bold&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;OR&lt;/bold&gt;&lt;xref ref-type=&quot;fn&quot; rid=&quot;t2-fn2&quot;&gt;a&lt;/xref&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;95% CI&lt;/bold&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;&lt;italic&gt;N&lt;/italic&gt;&lt;/bold&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;OR&lt;/bold&gt;&lt;xref ref-type=&quot;fn&quot; rid=&quot;t2-fn2&quot;&gt;a&lt;/xref&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;95% CI&lt;/bold&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;&lt;italic&gt;N&lt;/italic&gt;&lt;/bold&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;OR&lt;/bold&gt;&lt;xref ref-type=&quot;fn&quot; rid=&quot;t2-fn2&quot;&gt;a&lt;/xref&gt;&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;&lt;bold&gt;95% CI&lt;/bold&gt;&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody valign=&quot;top&quot;&gt;&lt;tr&gt;&lt;td colspan=&quot;11&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;&lt;italic&gt;Prenatal vitamins&lt;/italic&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;11&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âAny prenatal vitamin consumption&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;19&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;40&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;28&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;11&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;303&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;402&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.79&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.44â1.42&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;235&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.63&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.34â1.18&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;161&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.20&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.53â2.75&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;11&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âPericonceptional consumption&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;100&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;162&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;104&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;56&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;222&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;280&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.89&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.64â1.24&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;159&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.77&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.54â1.11&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;116&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.05&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.68â1.61&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;11&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âConsumption during pregnancy, after confirmation of pregnancy&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;29&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;58&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;39&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;18&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;293&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;384&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.78&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.48â1.28&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;224&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.66&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.39â1.11&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;154&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.05&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.55â2.04&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;11&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âConsumption in year before and throughout pregnancy&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;137&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;222&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;137&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;83&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;185&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;220&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.84&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.62â1.14&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;126&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.77&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.55â1.09&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;89&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.88&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.60â1.31&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;11&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;&lt;italic&gt;Prenatal iron supplements&lt;/italic&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;11&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âAny prenatal iron consumption&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;253&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;334&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;195&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;136&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;70&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;108&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.07&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.75â1.52&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;68&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.22&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.82â1.80&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;36&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.82&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.51â1.33&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;11&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âPericonceptional consumption&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;308&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;414&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;247&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;160&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;15&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;28&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.23&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.63â2.38&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;16&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.30&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.62â2.72&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;12&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.26&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.55â2.88&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;11&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âConsumption during pregnancy, after confirmation of pregnancy&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;260&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;345&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;201&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;141&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;63&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;97&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.06&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.74â1.53&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;62&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.22&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.81â1.84&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;31&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;0.77&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.46â1.27&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;11&quot; align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;âConsumption in year before and throughout pregnancy&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââNo&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;320&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;431&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;256&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;168&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.00&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;Â &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; charoff=&quot;50&quot;&gt;ââYes&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;11&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;2.54&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.69â9.39&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;3.04&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.77â12.03&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;4&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;.&quot; charoff=&quot;50&quot;&gt;1.72&lt;/td&gt;&lt;td align=&quot;char&quot; valign=&quot;top&quot; char=&quot;â&quot; charoff=&quot;50&quot;&gt;0.33â9.06&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>20147</offset><text>Â 	Controls	Combined cases	ALL	AML	 	Â 	N	N	ORa	95% CI	N	ORa	95% CI	N	ORa	95% CI	 	Prenatal vitamins	 	âAny prenatal vitamin consumption	 	ââNo	19	40	1.00	Â 	28	1.00	Â 	11	1.00	Â 	 	ââYes	303	402	0.79	0.44â1.42	235	0.63	0.34â1.18	161	1.20	0.53â2.75	 	âPericonceptional consumption	 	ââNo	100	162	1.00	Â 	104	1.00	Â 	56	1.00	Â 	 	ââYes	222	280	0.89	0.64â1.24	159	0.77	0.54â1.11	116	1.05	0.68â1.61	 	âConsumption during pregnancy, after confirmation of pregnancy	 	ââNo	29	58	1.00	Â 	39	1.00	Â 	18	1.00	Â 	 	ââYes	293	384	0.78	0.48â1.28	224	0.66	0.39â1.11	154	1.05	0.55â2.04	 	âConsumption in year before and throughout pregnancy	 	ââNo	137	222	1.00	Â 	137	1.00	Â 	83	1.00	Â 	 	ââYes	185	220	0.84	0.62â1.14	126	0.77	0.55â1.09	89	0.88	0.60â1.31	 	Â 	Â 	Â 	Â 	Â 	Â 	Â 	Â 	Â 	Â 	Â 	 	Prenatal iron supplements	 	âAny prenatal iron consumption	 	ââNo	253	334	1.00	Â 	195	1.00	Â 	136	1.00	Â 	 	ââYes	70	108	1.07	0.75â1.52	68	1.22	0.82â1.80	36	0.82	0.51â1.33	 	âPericonceptional consumption	 	ââNo	308	414	1.00	Â 	247	1.00	Â 	160	1.00	Â 	 	ââYes	15	28	1.23	0.63â2.38	16	1.30	0.62â2.72	12	1.26	0.55â2.88	 	âConsumption during pregnancy, after confirmation of pregnancy	 	ââNo	260	345	1.00	Â 	201	1.00	Â 	141	1.00	Â 	 	ââYes	63	97	1.06	0.74â1.53	62	1.22	0.81â1.84	31	0.77	0.46â1.27	 	âConsumption in year before and throughout pregnancy	 	ââNo	320	431	1.00	Â 	256	1.00	Â 	168	1.00	Â 	 	ââYes	3	11	2.54	0.69â9.39	7	3.04	0.77â12.03	4	1.72	0.33â9.06	 	</text></passage><passage><infon key="file">tbl2.xml</infon><infon key="id">tbl2</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>21715</offset><text>Abbreviations: 95% CI=95% confidence interval; ALL=acute lymphoblastic leukaemia; AML=acute myeloid leukaemia; OR=odds ratio.</text></passage><passage><infon key="file">tbl2.xml</infon><infon key="id">tbl2</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>21841</offset><text>ORs adjusted for maternal race and household income.</text></passage></document></collection>
